Funder
Giovanni Armenise-Harvard Foundation
Ministero della Salute
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy
Reference50 articles.
1. Fisher, D. & Wilder-Smith, A. The global community needs to swiftly ramp up the response to contain COVID-19. Lancet 395, 1109–1110 (2020).
2. Celardo, I., Pace, L., Cifaldi, L., Gaudio, C. & Barnaba, V. The immune system view of the coronavirus SARS-CoV-2. Biol. Direct 15, 30 (2020).
3. Thomas, S. J. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. N. Engl. J. Med. 385, 1761–1773 (2021).
4. Moderna. Moderna Reports Second Quarter Fiscal Year 2021 Financial Results and Provides Business Updates. Press release (2021).
5. Regev-Yochay, G. et al. Decreased infectivity following BNT162b2 vaccination: a prospective cohort study in Israel. Lancet Reg. Health Eur. 7, 100150 (2021).